Fixing Broken IDH1 in Cholangiocarcinoma: How Inhibitors Are Changing the Fight By Steve|2024-10-13T19:18:45+13:00October 1st, 2024|Categories: All, Q&A, Z-Legacy|Tags: IDH1, IDH2, Mitochondria| Read More 0
IDH1-Mutated Cholangiocarcinoma: Understanding PARP Inhibitors and Clinical Trials By Steve|2024-10-14T16:43:27+13:00September 25th, 2024|Categories: All, Q&A, Z-Legacy|Tags: ATR Inhibitors, clinical, Clinical Trial, iCCA, IDH1 Mutation, PARP Inhibitors, RAD-3, Shruti| Read More 0
Michael Flannery: Life Goes On: My Journey with Cholangiocarcinoma By Steve|2024-10-13T19:18:48+13:00September 24th, 2024|Categories: All, Z-Legacy|Tags: Michael Flannery, patient| Read More 0
Steve Holmes Patient Survivor: 14000 kilometre Cycling Circumnavigation of Australia By Steve|2024-10-13T19:18:49+13:00September 16th, 2024|Categories: All, Patient Story, Z-Legacy|Tags: Cholangio Challenger, Steve Holmes| Read More 0
The Checkpoint Pathway: Ipilimumab and Keytruda immunotherapy combination By Steve|2024-10-13T19:18:51+13:00September 15th, 2024|Categories: All, Treatments, Z-Legacy|Tags: Ipilum| Read More 0
Lynette Williams Beats Cholangiocarcinoma and Joins Light Australia Green By Steve|2024-10-13T19:18:53+13:00August 17th, 2024|Categories: All, PATIENT, Patient Story, Z-Legacy|Tags: Coffs Harbour, Light Australia Green, Lynette Williams, New South Wales, Patient Success| Read More 0
Understanding BRCA1 and BRCA2 in Cholangiocarcinoma By Steve|2024-10-13T19:18:54+13:00August 10th, 2024|Categories: All, Genes, Z-Legacy|Tags: BAP1, BRCA1, BRCA2, Clinical Trial| Read More 0
Exploring the TAS-120-205 Trial: Understanding FGFR2 Inhibitor Impact on Cholangiocarcinoma Treatment” By Steve|2024-10-13T19:18:56+13:00July 31st, 2024|Categories: All, Drug Reviews, Trials & Studies, Z-Legacy|Tags: 120-205, Clinical Trial, FGFR2, TAS, Tiaho| Read More 0
Bile Gone Bad-Article 3: Understanding Bile Duct Damage and Bile Duct Cancers By Steve|2024-10-13T19:18:57+13:00July 21st, 2024|Categories: All, Bile Gone Bad, Investigative, Z-Legacy|Tags: Bile Gone Bad| Read More 0
Meet GEM/CIS/DURVA: A Formidable Trio in the Fight Against Cancer By Steve|2024-10-13T19:18:59+13:00July 18th, 2024|Categories: All, Treatments, Trials & Studies, Z-Legacy|Tags: durvalumab, Gem/Cis/Durva| Read More 0
Silent Chronic Inflammation and Rising Cholangiocarcinoma, Especially in Younger Patients By Steve|2024-10-13T19:19:01+13:00July 17th, 2024|Categories: All, Bile Gone Bad, Z-Legacy|Tags: Bile Gone Bad| Read More 0
Bile Gone Bad: The Rising Incidence of Bile Duct Cancer – The Hidden Dangers within Bile Composition By Steve|2024-10-13T19:19:03+13:00July 9th, 2024|Categories: All, Trials & Studies, Z-Legacy|Tags: Bile Gone Bad| Read More 0
Unlocking the Power of Immunotherapy and Gem/Cis: A Strategic Battle Plan for Fighting Cholangiocarcinoma By Steve|2024-10-13T19:19:05+13:00July 8th, 2024|Categories: All, Drug Reviews, Trials & Studies, Z-Legacy|Tags: Gem/Cis/Durva, Gem/Cis/Keytruda| Read More 0
Meet Olaparib: A Key Player in the Fight Against Cancer By Steve|2024-10-13T19:19:08+13:00July 2nd, 2024|Categories: All, Drug Reviews, Z-Legacy|Tags: olaparib, PARP Inhibitor| Read More 0
Defeating Biliary Tract Cancer with ARTEMIDE-Biliary01: A New Hope By Steve|2024-10-11T15:58:46+13:00July 2nd, 2024|Categories: All, Trials & Studies, Z-Legacy|Tags: ARTEMIDE-Biliary01, PD-1, PD-L1, Rilvegostomig, TIGIT| Read More 0
AMG193 Trial targets MTAP Loss By Steve|2024-10-11T15:58:53+13:00June 25th, 2024|Categories: All, Trials & Studies, Z-Legacy|Tags: MTAP Loss| Read More 0